A phase II trial of 506U78 (IND 52611) [nelarabine] in patients with relapsed or refractory non T-cell acute lymphoblastic leukemia (ALL).
Phase of Trial: Phase II
Latest Information Update: 13 Jan 2012
At a glance
- Drugs Nelarabine (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Therapeutic Use
- 25 Sep 2005 New trial record.